BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND ERCC4, XPF, 2072, ENSG00000175595, Q92889
22 results:

  • 1. DNA Methylation Profiling Distinguishes Adamantinoma-Like Ewing Sarcoma From Conventional Ewing Sarcoma.
    Fritchie KJ; Ameline B; Andrei V; Griffith C; Shah AA; Dermawan JK; Trucco M; Budd T; Thangaiah JJ; Molligan J; Whaley RD; Magliocca K; Azzato E; van Zante A; Jo V; Xu B; Bishop JA; Rooper L; Baumhoer D
    Mod Pathol; 2023 Nov; 36(11):100301. PubMed ID: 37567448
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in
    Astiazaran-Symonds E; Graham C; Kim J; Tucker MA; Ingvar C; Helgadottir H; Pastorino L; van Doorn R; Sampson JN; Zhu B; Bruno W; Queirolo P; Fornarini G; Sciallero S; Carter B; Hicks B; Hutchinson A; Jones K; Stewart DR; Chanock SJ; Freedman ND; Landi MT; Höiom V; Puig S; Gruis N; Yang XR; Ghiorzo P; Goldstein AM
    JCO Precis Oncol; 2022 Nov; 6():e2200145. PubMed ID: 36409970
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Individualized combination therapies based on whole-exome sequencing displayed significant clinical benefits in a glioblastoma patient with secondary osteosarcoma: case report and genetic characterization.
    Yi GZ; Zhu TC; Que TS; Li ZY; Huang GL
    BMC Neurol; 2022 Oct; 22(1):390. PubMed ID: 36271359
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual Patient Report for 2018 and Annual Treatment Report for 2013.
    Nagase S; Ohta T; Takahashi F; Yamagami W; Yaegashi N;
    J Obstet Gynaecol Res; 2022 Mar; 48(3):541-552. PubMed ID: 35026864
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in the Childhood Cancer Survivor Study.
    Kim J; Gianferante M; Karyadi DM; Hartley SW; Frone MN; Luo W; Robison LL; Armstrong GT; Bhatia S; Dean M; Yeager M; Zhu B; Song L; Sampson JN; Yasui Y; Leisenring WM; Brodie SA; de Andrade KC; Fortes FP; Goldstein AM; Khincha PP; Machiela MJ; McMaster ML; Nickerson ML; Oba L; Pemov A; Pinheiro M; Rotunno M; Santiago K; Wegman-Ostrosky T; Diver WR; Teras L; Freedman ND; Hicks BD; Zhu B; Wang M; Jones K; Hutchinson AA; Dagnall C; Savage SA; Tucker MA; Chanock SJ; Morton LM; Stewart DR; Mirabello L
    JNCI Cancer Spectr; 2021 Apr; 5(2):. PubMed ID: 34308104
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. 12 Survival-related differentially expressed genes based on the TARGET-osteosarcoma database.
    Rothzerg E; Xu J; Wood D; Kõks S
    Exp Biol Med (Maywood); 2021 Oct; 246(19):2072-2081. PubMed ID: 33926256
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Evaluation of total scapular arthroplasty after total scapulectomy for scapular tumors].
    Li J; Bi J; Zhao X; Yao P; Liu Y; Bi W
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2020 Feb; 34(2):179-183. PubMed ID: 32030948
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. SLX4IP Antagonizes Promiscuous BLM Activity during ALT Maintenance.
    Panier S; Maric M; Hewitt G; Mason-Osann E; Gali H; Dai A; Labadorf A; Guervilly JH; Ruis P; Segura-Bayona S; Belan O; Marzec P; Gaillard PL; Flynn RL; Boulton SJ
    Mol Cell; 2019 Oct; 76(1):27-43.e11. PubMed ID: 31447390
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Germline Mutations in Cancer Predisposition Genes are Frequent in Sporadic sarcomas.
    Chan SH; Lim WK; Ishak NDB; Li ST; Goh WL; Tan GS; Lim KH; Teo M; Young CNC; Malik S; Tan MH; Teh JYH; Chin FKC; Kesavan S; Selvarajan S; Tan P; Teh BT; Soo KC; Farid M; Quek R; Ngeow J
    Sci Rep; 2017 Sep; 7(1):10660. PubMed ID: 28878254
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Somatic mutations in histiocytic sarcoma identified by next generation sequencing.
    Liu Q; Tomaszewicz K; Hutchinson L; Hornick JL; Woda B; Yu H
    Virchows Arch; 2016 Aug; 469(2):233-41. PubMed ID: 27259537
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Genetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma.
    Wang MJ; Zhu Y; Guo XJ; Tian ZZ
    Genet Mol Res; 2015 Sep; 14(3):11652-7. PubMed ID: 26436406
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Genetic polymorphisms in nucleotide excision repair pathway influences response to chemotherapy and overall survival in osteosarcoma.
    Sun Y; Wu Y; Li W; Kong Z; Zou X
    Int J Clin Exp Pathol; 2015; 8(7):7905-12. PubMed ID: 26339355
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Systematic review of surgery and outcomes in patients with primary aldosteronism.
    Muth A; Ragnarsson O; Johannsson G; Wängberg B
    Br J Surg; 2015 Mar; 102(4):307-17. PubMed ID: 25605481
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Role of endonucleases xpf and XPG in nucleotide excision repair of platinated DNA and cisplatin/oxaliplatin cytotoxicity.
    Graf N; Ang WH; Zhu G; Myint M; Lippard SJ
    Chembiochem; 2011 May; 12(7):1115-23. PubMed ID: 21452186
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up.
    Penel N; Le Cesne A; Bui BN; Perol D; Brain EG; Ray-Coquard I; Guillemet C; Chevreau C; Cupissol D; Chabaud S; Jimenez M; Duffaud F; Piperno-Neumann S; Mignot L; Blay JY
    Ann Oncol; 2011 Feb; 22(2):452-7. PubMed ID: 20622000
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.
    Caronia D; Patiño-García A; Milne RL; Zalacain-Díez M; Pita G; Alonso MR; Moreno LT; Sierrasesumaga-Ariznabarreta L; Benítez J; González-Neira A
    Pharmacogenomics J; 2009 Oct; 9(5):347-53. PubMed ID: 19434073
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Von Hippel-Lindau-coupled and transcription-coupled nucleotide excision repair-dependent degradation of RNA polymerase II in response to trabectedin.
    Aune GJ; Takagi K; Sordet O; Guirouilh-Barbat J; Antony S; Bohr VA; Pommier Y
    Clin Cancer Res; 2008 Oct; 14(20):6449-55. PubMed ID: 18927284
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Expressions of ERCC2 and ercc4 genes in osteosarcoma and peripheral blood lymphocytes and their clinical significance].
    Li X; Guo W; Shen DH; Yang RL; Liu J; Zhao H
    Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Oct; 39(5):467-71. PubMed ID: 17940561
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Expression of genes of potential importance in the response to chemotherapy in osteosarcoma patients].
    Nathrath M; Kremer M; Letzel H; Remberger K; Höfler H; Ulle T
    Klin Padiatr; 2002; 214(4):230-5. PubMed ID: 12165907
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Primary pleuropulmonary synovial sarcoma: reappraisal of a recently described anatomic subset.
    Essary LR; Vargas SO; Fletcher CD
    Cancer; 2002 Jan; 94(2):459-69. PubMed ID: 11905413
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.